Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study

This publication has 24 references indexed in Scilit:

• Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
  The Lancet Diabetes & Endocrinology, 2016
• Máxima reducción de colesterol unido a lipoproteínas de baja densidad alcanzable con combinaciones farmacológicas. Cuando 50 más 20 suma 60
  Revista Espanola de Cardiologia, 2016
• The Agenda for Familial Hypercholesterolemia
  Circulation, 2015
• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
  New England Journal of Medicine, 2015
• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
  European Heart Journal, 2013
• Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
  New England Journal of Medicine, 2011
• Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
  Lipids in Health and Disease, 2011
• Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
  JACC, 2010
• Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study
  European Heart Journal, 2006
• Beneficial Cardiovascular Pleiotropic Effects of Statins
  Circulation, 2004